Cardiovascular Implants Market By Procedure type ( Angioplasty, Open heart surgery ), By Material ( Metals & Alloys, Polymers, Biological Materials ), By Device ( Implantable Cardioverter-Defibrillators, Cardiac Pacemakers, Cardiac Resynchronization Therapy Devices, TAVR valves, Coronary Stents ), Industry Trends, Estimation & Forecast, 2017-2025

Check Today's Best Price

$3500 Buy Now
Cardiovascular Implants Market is expected to grow with a CAGR of 4.3% during the forecast period of 2018 to 2025.
  • Market Overview:

    Cardiovascular implants are delicate and vital devices used to replace an unhealthy heart as they mimic the functions of a healthy heart. Technological advancements in the healthcare industry have led to the advent of cardiovascular implants made up of different materials such as metals, polymers, and even biological materials. Among all the available implants, pacemakers are the most widely used cardiac implants that regulate the heart beats at a stable pace. The surging incidences of cardiovascular diseases across the globe is the major determinant that is fuelling the growth of global cardiovascular implants market. According to the American College of Cardiology, majority of deaths caused due to cardiovascular diseases (CVD) is linked to coronary heart diseases followed by heart failure and stroke.

    Coronary heart disease is the major cause of CVD deaths in the United States. Whereas, every 1 in 20 deaths occurring in the U.S. is caused due to stroke. Moreover, the increasing number of geriatric population in the world is also catalyzing the demand for cardiovascular implants in the current market scenario. As per the data revealed by AARP, approximately 3, 70,000 cardiac pacemakers are received by the American population each year. In the cardiovascular implants market, the buyers are gaining higher bargaining power over the market players by acquiring or merging with other prominent buyers. The global market of cardiovascular implants is experiencing hurdles in its growth due to the unavailability of sufficient data regarding the performance, effectiveness, and quality of such devices, which restricts the capability of buyers to evaluate the value of such devices. However, increasing technological advancements and surging healthcare investments are anticipated to render lucrative opportunities to the market players during the upcoming years.

    The report provides detailed qualitative and quantitative analysis of the cardiovascular implants market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely procedure type, material, device, and application in each of the major regions.

    Cardiovascular Implants Market Segmentation

    By Procedure Type
    • Angioplasty
    • Open heart surgery

    By Material
    • Metals & Alloys
    • Polymers
    • Biological Materials

    By Device
    • Implantable Cardioverter-Defibrillators
    • Cardiac Pacemakers
    • Cardiac Resynchronization Therapy Devices
    • TAVR valves
    • Coronary Stents
    • Others

    By Application
    • Arrhythmias
    • Myocardial Ischemia
    • Acute Myocardial Infarction
    • Congestive Heart Failure
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. CARDIOVASCULAR IMPLANTS MARKET OVERVIEW
    2.1. CARDIOVASCULAR IMPLANTS MARKET INTRODUCTION
    2.2. GLOBAL CARDIOVASCULAR IMPLANTS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Cardiovascular Implants Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Cardiovascular Implants Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Cardiovascular Implants Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Cardiovascular Implants Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    2.6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET PRICE TREND, 2017-2025
    2.6.1. Global Cardiovascular Implants Market Price Trend and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET BY DEVICE, 2017-2025
    3.1. IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    3.2. CARDIAC PACEMAKERS
    3.3. CARDIAC RESYNCHRONIZATION THERAPY DEVICES
    3.4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET REVENUE BY DEVICE, 2017-2025
    3.4.1. Global Cardiovascular Implants Market Revenue (Million USD) and Share (%) By Device, 2017-2025
    3.4.2. Implantable Cardioverter-Defibrillators Market Revenue and Growth Rate, 2017-2025
    3.4.3. Cardiac Pacemakers Market Revenue and Growth Rate, 2017-2025
    3.4.4. Cardiac Resynchronization Therapy Devices Market Revenue and Growth Rate, 2017-2025
    3.5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET PRODUCTION BY DEVICE, 2017-2025
    3.5.1. Global Cardiovascular Implants Market Production (Volume) and Share (%) By Device, 2017-2025
    3.5.2. Implantable Cardioverter-Defibrillators Market Production and Growth Rate, 2017-2025
    3.5.3. Cardiac Pacemakers Market Production and Growth Rate, 2017-2025
    3.5.4. Cardiac Resynchronization Therapy Devices Market Production and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for procedure type and material segment.

    CHAPTER 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET BY APPLICATION, 2017-2025
    4.1. ARRHYTHMIAS
    4.2. MYOCARDIAL ISCHEMIA
    4.3. ACUTE MYOCARDIAL INFARCTION
    4.4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. Global Cardiovascular Implants Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.4.2. Arrhythmias Market Revenue and Growth Rate, 2017-2025
    4.4.3. Myocardial Ischemia Market Revenue and Growth Rate, 2017-2025
    4.4.4. Acute Myocardial Infarction Market Revenue and Growth Rate, 2017-2025
    4.5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.5.1. Global Cardiovascular Implants Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.5.2. Arrhythmias Market Consumption and Growth Rate, 2017-2025
    4.5.3. Myocardial Ischemia Market Consumption and Growth Rate, 2017-2025
    4.5.4. Acute Myocardial Infarction Market Consumption and Growth Rate, 2017-2025

    CHAPTER 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Cardiovascular Implants Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL CARDIOVASCULAR IMPLANTS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    6.1.1. Global Cardiovascular Implants Market Production (Volume) and Share (%) By Region, 2017-2025
    6.1.2. Global Cardiovascular Implants Market Consumption (Volume) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL CARDIOVASCULAR IMPLANTS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global Cardiovascular Implants Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL CARDIOVASCULAR IMPLANTS REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global Cardiovascular Implants Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. CARDIOVASCULAR IMPLANTS MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. Cardiovascular Implants Market Share (%) of Top 3 Manufacturers
    8.3.2. Cardiovascular Implants Market Share (%) of Top 5 Manufacturers

    CHAPTER 9. GLOBAL CARDIOVASCULAR IMPLANTS MANUFACTURERS ANALYSIS
    9.1. BIOTRONIK
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. Cardiovascular Implants Product Details
    9.1.4. Biotronik Cardiovascular Implants Production, Revenue and Gross Margin
    9.2. ABBOTT LABORATORIES
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. Cardiovascular Implants Product Details
    9.2.4. Abbott Laboratories Cardiovascular Implants Production, Revenue and Gross Margin
    9.3. ST. JUDE MEDICAL
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. Cardiovascular Implants Product Details
    9.3.4. St. Jude Medical Cardiovascular Implants Production, Revenue and Gross Margin
    9.4. AMG INTERNATIONAL
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. Cardiovascular Implants Product Details
    9.4.4. AMG International Cardiovascular Implants Production, Revenue and Gross Margin
    9.5. B-BRAUN
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. Cardiovascular Implants Product Details
    9.5.4. B-Braun Cardiovascular Implants Production, Revenue and Gross Margin
    9.6. JOHNSON & JOHNSON
    9.6.1. Business Overview
    9.6.2. Company Basic Information
    9.6.3. Cardiovascular Implants Product Details
    9.6.4. Johnson & Johnson Cardiovascular Implants Production, Revenue and Gross Margin
    9.7. W.L. GORE & ASSOCIATES
    9.7.1. Business Overview
    9.7.2. Company Basic Information
    9.7.3. Cardiovascular Implants Product Details
    9.7.4. W.L. Gore & Associates Cardiovascular Implants Production, Revenue and Gross Margin
    9.8. MEDTRONIC
    9.8.1. Business Overview
    9.8.2. Company Basic Information
    9.8.3. Cardiovascular Implants Product Details
    9.8.4. Medtronic Cardiovascular Implants Production, Revenue and Gross Margin
    9.9. BOSTON SCIENTIFIC
    9.9.1. Business Overview
    9.9.2. Company Basic Information
    9.9.3. Cardiovascular Implants Product Details
    9.9.4. Boston Scientific Cardiovascular Implants Production, Revenue and Gross Margin
    9.10. ON-X LIFE TECHNOLOGIES
    9.10.1. Business Overview
    9.10.2. Company Basic Information
    9.10.3. Cardiovascular Implants Product Details
    9.10.4. On-X Life Technologies Cardiovascular Implants Production, Revenue and Gross Margin

    CHAPTER 10. CARDIOVASCULAR IMPLANTS MARKET VALUE CHAIN ANALYSIS
    10.1. CARDIOVASCULAR IMPLANTS INDUSTRIAL CHAIN ANALYSIS
    10.2. CARDIOVASCULAR IMPLANTS KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. CONSUMER ANALYSIS
    10.3.1. Consumer 1
    10.3.2. Consumer 2
    10.3.3. Consumer 3
    10.3.4. Consumer 4

    keyboard_arrow_up
  • • Biotronik
    • Abbott Laboratories
    • St. Jude Medical
    • AMG International
    • B-Braun
    • Johnson & Johnson
    • W.L. Gore & Associates
    • Medtronic
    • Boston Scientific
    • Sorin
    • Edwards Lifesciences
    • Fortimedix
    • Neovasc
    • On-X Life Technologies
    • Proxy Biomedical
    • Reva Medical
    • Pacetronix

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Cardiovascular Implants Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions, and their comparative growth rate?
• Which technology is on trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Cardiovascular Implants Marketand their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS